Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

The launch of Eli Lilly's weight-loss drug Zepbound is going swimmingly in the U.S., Jefferies said Friday.

from Health and Science https://ift.tt/WvIOKnT
https://ift.tt/P0osHyh
https://ift.tt/OY4MZuq